February 25th, 2019 – Cubresa Inc., a world leader in PET inserts for MRI, has selected a Chinese distributor for its NuPET™ preclinical imaging product line. Cubresa is pleased to announce that it has signed an agreement with Worldwide Technology (S.H.) Co., Ltd. (WAD), a Shanghai-based distributor who specializes in the sale of life sciences related equipment in China.
“Cubresa is excited to partner with WAD as we expand our preclinical product line into China.” said James Schellenberg, President and CEO of Cubresa Inc. “We see China as a key market for our company and believe that WAD’s extensive experience in the life sciences sector, and in-depth knowledge of the medical device market, will create significant opportunities for Cubresa.”
“Cubresa’s NuPET system has huge potential in China.” said Steven Zhu, General Manager of WAD. “ The medical professionals we speak to believe that simultaneous PET/MRI imaging is the future of both clinical and preclinical imaging in specific research areas including oncology, neurological disease and cardiovascular research. Cubresa and WAD are well positioned in this emerging market in China.”
In addition to entering the Chinese preclinical imaging marketplace with its preclinical NuPET product line, Cubresa recently announced a Joint Venture in China that sees the company expanding into the clinical imaging space.